Intranasal GLP-1 Delivery for Addiction and Reward Circuit Modulation
Intranasal delivery bypasses the blood-brain barrier to reach addiction's core neural circuits.
Tobias Mehring
Contributing Editor, Nanomedicine
Tobias Mehring
Tobias Mehring holds a doctoral background in materials chemistry from a German research institute and has been writing about drug delivery technology for trade and specialist audiences since 2008. He focuses on the engineering and safety science behind particulate carrier systems and their path from lab to clinic.
4 stories
Receptor-Mediated Transcytosis Across the Blood-Brain Barrier
Smart receptor-binding tricks unlock the brain's hidden import doors.
Tobias Mehring
GLP-1 Receptor Distribution in the Human Brain
Brain GLP-1 receptors cluster in cortex, not cerebellum, unlike rodents.
Tobias Mehring
GLP-1 Pharmacokinetics and Half-Life Engineering in Approved Analogs
Chemists engineered GLP-1's fatal flaw—its two-minute lifespan—into drugs dosed weekly.
Tobias Mehring